WallStSmart

ASP Isotopes Inc. Common Stock (ASPI)vsMethanex Corporation (MEOH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Methanex Corporation generates 13516% more annual revenue ($3.67B vs $26.93M). ASPI leads profitability with a 0.0% profit margin vs -1.2%. MEOH earns a higher WallStSmart Score of 60/100 (C).

ASPI

Avoid

31

out of 100

Grade: F

Growth: 6.3Profit: 2.5Value: 6.7Quality: 6.0
Piotroski: 4/9Altman Z: -0.12

MEOH

Buy

60

out of 100

Grade: C

Growth: 6.0Profit: 4.5Value: 6.3Quality: 4.5
Piotroski: 2/9Altman Z: 1.49
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ASPIUndervalued (+80.8%)

Margin of Safety

+80.8%

Fair Value

$29.49

Current Price

$6.71

$22.78 discount

UndervaluedFair: $29.49Overvalued
MEOHOvervalued (-6.1%)

Margin of Safety

-6.1%

Fair Value

$46.43

Current Price

$57.62

$11.19 premium

UndervaluedFair: $46.43Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ASPI2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
279.3%10/10

Revenue surging 279.3% year-over-year

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

MEOH3 strengths · Avg: 9.3/10
PEG RatioValuation
0.2010/10

Growing faster than its price suggests

EPS GrowthGrowth
78.1%10/10

Earnings expanding 78.1% YoY

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

Areas to Watch

ASPI4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$950.57M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-60.0%2/10

ROE of -60.0% — below average capital efficiency

MEOH4 concerns · Avg: 2.8/10
Return on EquityProfitability
0.6%3/10

ROE of 0.6% — below average capital efficiency

Debt/EquityHealth
1.433/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.492/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ASPI

The strongest argument for ASPI centers on Revenue Growth, Price/Book. Revenue growth of 279.3% demonstrates continued momentum.

Bull Case : MEOH

The strongest argument for MEOH centers on PEG Ratio, EPS Growth, Price/Book. PEG of 0.20 suggests the stock is reasonably priced for its growth.

Bear Case : ASPI

The primary concerns for ASPI are EPS Growth, Market Cap, Profit Margin.

Bear Case : MEOH

The primary concerns for MEOH are Return on Equity, Debt/Equity, Piotroski F-Score.

Key Dynamics to Monitor

ASPI profiles as a hypergrowth stock while MEOH is a turnaround play — different risk/reward profiles.

ASPI carries more volatility with a beta of 3.27 — expect wider price swings.

ASPI is growing revenue faster at 279.3% — sustainability is the question.

MEOH generates stronger free cash flow (110M), providing more financial flexibility.

Bottom Line

MEOH scores higher overall (60/100 vs 31/100). ASPI offers better value entry with a 80.8% margin of safety. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

ASP Isotopes Inc. Common Stock

BASIC MATERIALS · CHEMICALS · USA

Aspire Real Estate Investors, Inc. focuses on investing, developing, remodeling and managing a portfolio of multi-family properties in metropolitan areas of the United States. The company is headquartered in Irvine, California.

Methanex Corporation

BASIC MATERIALS · CHEMICALS · USA

Methanex Corporation produces and supplies methanol in North America, Asia Pacific, Europe, and South America. The company is headquartered in Vancouver, Canada.

Want to dig deeper into these stocks?